Heska Corporation (HSKA) |
| 119.99 0 (0%) 06-12 16:00 |
| Open: | 119.96 |
| High: | 119.99 |
| Low: | 119.99 |
| Volume: | 330,887 |
| Market Cap: | 1,310(M) |
| PE Ratio: | -62.49 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 140.15 |
| Resistance 1: | 119.99 |
| Pivot price: | 118.82 |
| Support 1: | 117.17 |
| Support 2: | 115.42 |
| 52w High: | 120.03 |
| 52w Low: | 57.83 |
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
| EPS | -1.920 |
| Book Value | 38.260 |
| PEG Ratio | -5.71 |
| Gross Profit | 10.190 |
| Profit Margin (%) | -7.86 |
| Operating Margin (%) | -9.40 |
| Return on Assets (ttm) | -2.5 |
| Return on Equity (ttm) | -4.7 |
Mon, 03 Apr 2023
Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions - PR Newswire
Tue, 03 Jan 2023
Heska Corporation Completes Acquisition of LightDeck Diagnostics - PR Newswire
Mon, 12 Sep 2022
Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts - PR Newswire
Mon, 03 Jan 2022
Heska Corporation Completes Acquisition of VetZ GmbH to Become European Leader in Practice Management Software Solutions - PR Newswire
Thu, 14 Oct 2021
We Think Heska (NASDAQ:HSKA) Can Stay On Top Of Its Debt - Nasdaq
Thu, 01 Apr 2021
Heska Is Up More Than 70% in 6 Months -- Is It Too Late to Buy the Stock? - The Motley Fool
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |